Atlas Venture Life Science Advisors, LLC Vigil Neuroscience, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $341 Million
- Q1 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,836,874 shares of VIGL stock, worth $47 Million. This represents 3.04% of its overall portfolio holdings.
Number of Shares
5,836,874
Previous 5,836,874
-0.0%
Holding current value
$47 Million
Previous $9.81 Million
5.96%
% of portfolio
3.04%
Previous 1.62%
Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
57Shares Held
28.3MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$32.3 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.8 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$14 Million0.25% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.6MShares$12.9 Million0.75% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...